Randomized, double-blind, placebo-controlled study of the preventive effect of supplemental oral vitamin C on attenuation of development of nitrate tolerance

Journal of the American College of Cardiology

Volumn 31, Issue 6, 1998, Pages 1323-1329

  Watanabe, Hideki ^a   Kakihana, Masaaki ^a,b   Ohtsuka, Sadanori ^a,c   Sugishita, Yasuro ^a,c  

^a KINU Medical Association Hospital   (Japan)

^b IBARAKI PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; GLYCERYL TRINITRATE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; DRUG TOLERANCE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBLINGUAL DRUG ADMINISTRATION; VASODILATATION;

ADULT; AGED; ANTIOXIDANTS; ASCORBIC ACID; CYCLIC GMP; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NITROGLYCERIN; PLETHYSMOGRAPHY; VASODILATOR AGENTS;

EID: 0032080947     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00085-0     Document Type: Article

References (47)

1. Abrams J. Tolerance to organic nitrates. Circulation 1986;74:1181-5.
2. Packer M, Lee W, Kessler P, Gottlieb S, Medina N, Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 1987;317:799-804.
3. Fung H. Solving the mystery of nitrate tolerance: a new scent on the trail? Circulation 1993;88:322-4.
4. Parker J, Farrel B, Fenton T, Cohanim M, Parker J. Counterregulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation 1991;84:2336-45.
5. Dupuis J, Lalonde G, Lemieux R, Rouleau J. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. J Am Coll Cardiol 1990;16:922-31.
6. Waldman S, Rapoport R, Ginsburg R, Murad F. Desensitization to nitroglycerin in vascular smooth muscle from rat and human. Biochem Pharmacol 1986;35:3525-31.
7. Schröder H, Leitman D, Bennett B, Waldman S, Murad F. Glyceryl trinitrate-induced desensitization of guanylate cyclase in cultured rat lung fibroblasts. J Pharmacol Exp Ther 1988;245:413-8.
8. Münzel T, Sayegh H, Freeman B, Tarpey M, Harrison D. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. J Clin Invest 1995;95:187-94.
9. Münzel T, Giaid A, Kurz S, Stewart D, Harrison D. Evidence for a role of endothelin-1 and protein kinase C in nitrate tolerance. Proc Natl Acad Sci USA 1995;92:5244-8.
10. Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 1991;53 Suppl:314S-21S.
11. Watanabe H, Kakihana M, Ohtsuka S, Sugishita Y. Randomized, double-blind, placebo-controlled study of ascorbate on the preventive effect of nitrate tolerance in patients with congestive heart failure. Circulation 1998;97:886-91.
12. Watanabe H, Kakihana M, Ohtsuka S, Sugishita Y. Randomized, double-blind, placebo-controlled study of supplemental vitamin E on an attenuation of the development of nitrate tolerance. Circulation 1997;96:2545-50.
13. Watanabe H, Kakihana M, Ohtsuka S, Enomoto T, Yasui K, Sugishita Y. Platelet cyclic GMP: a potentially useful indicator to evaluate the effects of nitroglycerin and nitrate tolerance. Circulation 1993;88:29-36.
14. Honma M, Satoh T, Takezawa J, Ui M. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small volume samples from blood and tissue. Biochem Med 1977;18:257-73.
15. Crandall L, Leake C, Loevenhart A, Muehlberger C. Acquired tolerance to and cross-tolerance between the nitrous and nitric acid esters and sodium nitrite in man. J Pharmacol Exp Ther 1931;41:103.
16. Elkayam U, Aronow W. Glyceryl trinitrate (nitroglycerin) ointment and isosorbide dinitrate: a review of their pharmacological properties and therapeutic use. Drugs 1982;23:165-94.
17. Elkayam U. Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention. Ann Intern Med 1991;114:667-77.
18. Mangione N, Glasser S. Phenomenon of nitrate tolerance. Am Heart J 1994;128:137-46.
19. Münzel T, Kurz S, Heitzer T, Harrison D. New insights into mechanisms underlying nitrate tolerance. Am J Cardiol 1996;77:24C-30C.
20. Packer M. What causes tolerance to nitroglycerin? The 100 year old mystery continues. J Am Coll Cardiol 1990;16:932-5.
21. Slack C, McLaughlin B, Brien J, Marks G, Nakatsu K. Biotransformation of glyceryl trinitrate and isosorbide dinitrate in vascular smooth muscle made tolerant to organic nitrates. Can J Physiol Pharmacol 1989;67:1381-5.
22. Axelsson K, Andersson R. Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover. Eur J Pharmacol 1983;88:71-9.
23. Needleman P, Johnson EM Jr. Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther 1973;184:709-15.
24. Feelisch M, Nack EA. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 1987;139:19-30.
25. Katz R, Levy W, Buff L, Wasserman A. Prevention of nitrate tolerance with angiotensin converting enzyme inhibitors. Circulation 1991;83:1271-7.
26. Muiesan M, Boni E, Castellano M, et al. Effects of transdermal nitroglycerin in combination with an ACE-inhibitor in patients with chronic stable angina pectoris. Eur Heart J 1993;14:1701-8.
27. Pizzulli L, Hagendorff A, Zirbes M, et al. Influence of captopril on nitroglycerin-mediated vasodilation and development of nitrate tolerance in arterial and venous circulation. Am Heart J 1996;131:342-9.
28. Dakak N, Makhoul N, Flugelman M, et al. Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease. Am J Cardiol 1990;66:608-13.
29. Parker JD, Parker JO. Effect of therapy with an angiotensin-converting enzyme inhibitor on hemodynamic and counterregulatory response during continuous therapy with nitroglycerin. J Am Coll Cardiol 1993;21: 1445-53.
30. Münzel T, Bassenge E. Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo. Circulation 1996;93:2052-8.
31. Gogia H, Mehra A, Parikh S, et al. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. J Am Coll Cardiol 1995;26:1575-80.
32. Bauer J, Fung H. Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure. Circulation 1991;84:35-9.
33. Elkayam U. Prevention of nitrate tolerance with concomitant administration of hydralazine. Can J Cardiol 1996;12 Suppl C:17C-21C.
34. Frei B. Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am J Med 1994;97:5S-13S.
35. Benedich A, Machlin I, Scandurra O, Burton G, Wayner D. The antioxidant role of vitamin C. Adv Free Radic Bio Med 1986;2:419-44.
36. Gey K, Stahelin H, Puska P, Evans A. Relationship of plasma level of vitamin C to mortality from ischemic heart disease. Ann NY Acad Sci 1987;498:110-23.
37. Riemersma R, Wood D, Macintyre C, Elton R, Gey K, Oliver M. Low plasma vitamin E and C and increased risk of angina in Scottish men. Ann NY Acad Sci 1989;570:291-5.
38. Singh R, Niaz M, Bishnoi I, et al. Diet, antioxidant vitamins, oxidative stress and risk of coronary artery disease: the Peerzada Prospective Study. Acta Cardiol 1994;49:453-67.
39. Levine G, Frei B, Koulouris S, Gerhard M, Keaney J, Vita J. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996;93:1107-13.
40. Heitzer T, Just H, Münzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996;94:6-9.
41. Bassenge E, Fink B. Tolerance to nitrates and simultaneous upregulation of platelet activity prevented by enhancing antioxidant state. Naunyn Schmiedebergs Arch Pharmacol 1996;353:363-7.
42. Pohl U, Busse R. EDRF increase cyclic GMP in platelets during passage through the coronary vascular bed. Circ Res 1989;65:1798-803.
43. Rapoport R, Murad F. Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP. J Cyclic Nucl Pro Phosphoryl Res 1983;9:281-96.
44. Glass D, Frey W, Carr D, Goldberg N. Stimulation of human platelet guanylate cyclase by fatty acid. J Biol Chem 1977;252:1279-85.
45. Gerster H, Moser U. Is high-dose vitamin C intake associated with systemic conditioning? Nutr Res 1988;8:1327-32.
46. Igarashi O, Yonekawa Y, Fujiyama-Fujiyama Y. Synergistic action of vitamin E and vitamin C in vivo using a new mutant of Wistar-strain rats, ODS, unstable to synthesize vitamin C. J Nutr Sci Vitaminol 1991;37:359-69.
47. Yamauchi R, Kato K, Ueno Y. Reaction of 8a-hydroperoxy tocopherones with ascorbic acid. Agrc Biol Chem 1981;45:2855-61.